Carter Leads Bipartisan Effort Urging FDA to Allow for Office-Use Drug Compounding in Pharmacies
Today, Representatives Earl L. "Buddy" Carter (R-Georgia) and Chris Stewart (R-Utah) led a bipartisan group of 65 Members of Congress urging the Federal Drug Administration (FDA) to rescind their decision that restricts state-licensed pharmacies from compounding prescription drugs for health care providers to use in their offices. Drug compounding is used to prepare personalized…